Association of Novel Risk Factors With the Ankle Brachial Index in African American and Non-Hispanic White Populations

Khawaja, Farhan J.; Bailey, Kent R.; Turner, Stephen T.; Kardia, Sharon L.; Mosley Jr, Thomas H.; Kullo, Iftikhar J.
June 2007
Mayo Clinic Proceedings;Jun2007, Vol. 82 Issue 6, p709
Academic Journal
OBJECTIVES: To investigate whether novel risk factors, including C-reactive protein (CRP), fibrinogen, lipoprotein(a) [Lp(a)], and homocysteine levels, are associated with the ankle brachial index (ABI) in African American and non-Hispanic white populations and whether novel risk factors account for ethnic differences in peripheral arterial disease (PAD). PARTICIPANTS AND METHODS: Between December 2000 and October 2004, original participants in the Genetic Epidemiology Network of Arteriopathy study returned for a second study visit to undergo measurement of risk factors and ABI. The CRP, Lp(a), and homocysteine levels were log transformed to reduce skewness. Multivariable regression analyses were used to assess whether a novel risk factor was associated with ABI after adjustment for conventional risk factors and whether ethnicity was associated with PAD (ABI, ≤0.95) after adjustment for conventional and novel risk factors. RESULTS: Of 2229 study participants, the ABI was determined in 1395 African American participants (mean ±SD age, 63±9 years; 71% women) and 834 white participants (mean ± SD age, 58±9 years; 62% women) who belonged to hypertensive sibships. The mean ABI was lower in African American than in white individuals (0.99±0.1 vs 1.13±0.1; P<.001). In both ethnic groups, higher levels of CRP, fibrinogen, and homocysteine were each associated with a lower ABI after adjustment for conventional risk factors. In African American participants, the Lp(a) level was also significantly associated with the ABI. African American ethnicity was associated with the presence of PAD after adjustment for conventional risk factors (men: odds ratio [OR], 3.04; 95% confidence interval [Cl], 1.80–5.15; women: OR, 2.82; 95% CI, 1.85–4.29), but the risk was significantly attenuated after additional adjustment for novel risk factors (men: OR, 2.11; 95% Cl, 1.21–3.70; women: OR, 1.98; 95% CI, 1.26–3.11). CONCLUSION: Novel risk factors are associated with interindividual variation in ABI in African American and non-Hispanic white populations and partly account for the increased risk of PAD associated with African American ethnicity.


Related Articles

  • Emerging cardiac risk factors.  // Patient Care;5/30/2001, Vol. 35 Issue 10, p38 

    Discusses health factors which contribute to the development of coronary heart disease and atherosclerosis. Relation of the rise of C-reactive protein to the risk of getting a myocardial infraction; Generation of homocysteine connected with the metabolisim of amino acids; Fluctuations of...

  • The Far-Reaching Influence of Hepatic Enzyme-Inducing Antiepileptic Drugs. Abou-Khalil, Bassel W. // Epilepsy Currents;Nov/Dec2009, Vol. 9 Issue 6, p158 

    OBJECTIVE: The widely prescribed anticonvulsants phenytoin and carbamazepine are potent inducers of cytochrome P450 enzymes, which are involved in cholesterol synthesis. We sought to determine whether these drugs have an effect on cholesterol and other serological markers of vascular risk....

  • New Markers Predict Heart Disease Even Better; How To Lower Your Risk. Antinoro, Linda // Environmental Nutrition;Feb2007, Vol. 30 Issue 2, p1 

    The article discusses some predictors that can estimate the risk of heart disease. Low-density lipoprotein (LDL) measures the number of carriers transporting cholesterol to artery walls and the choice for predictor among health professionals. The c-reactive protein (CRP) may also be linked to...

  • Biomarkers of cardiovascular disease are possible risk factors for AMD. Talsma, Julia // Ophthalmology Times;5/1/2005, Vol. 30 Issue 9, p49 

    The article reports on a study which states that certain biomarkers of cardiovascular disease are possible risk factors for age-related macular degeneration (AMD). Researcher Andrew K. Vine and colleagues examined the levels of two markers for cardiovascular diseases--C-reactive protein (CRP)...

  • EDITORIAL. Milionis, Haralampos J.; Elisaf, Moses S. // Open Clinical Chemistry Journal;2010 Special Issue, p8 

    The article discusses various reports published within the issue including one which suggests that the determination of high sensitivity C-reactive protein (hsCRP) levels may be useful in therapeutic considerations, one the impact of serum total homocysteine (tHcy) on health status and the role...

  • Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Busch, Martin; Franke, Sybille; Müller, Andreas; Wolf, Marco; Gerth, Jens; Ott, Undine; Niwa, Toshimitsu; Stein, Günter // Kidney International;Jul2004, Vol. 66 Issue 1, p338 

    Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Background. Total homocysteine (tHcy) and advanced glycation end-products (AGEs) are implicated in the pathogenesis of vascular damage. This study aimed to...

  • Prevalence and determinants of chronic kidney disease in community-dwelling elderly by various estimating equations. Rothenbacher, Dietrich; Klenk, Jochen; Denkinger, Michael; Karakas, Mahir; Nikolaus, Thorsten; Peter, Richard; Koenig, Wolfgang // BMC Public Health;2012, Vol. 12 Issue 1, p343 

    Background: Chronic kidney disease (CKD) represents a global public health problem. Few data exist in the elderly. The objective of the current study is to estimate the prevalence of CKD by means of various established and new equations and to identify the main determinants of CKD in elderly....

  • Monitoring chronic diseases in Canada: the Chronic Disease Indicator Framework. Betancourt, M. T.; Roberts, K. C.; Bennett, T. L.; Driscoll, E. R.; Jayaraman, G.; Pelletier, L. // Maladies Chroniques et Blessures au Canada;Spring 2014 Supplement 1, Vol. 34 Issue 1, p1 

    Introduction: The Public Health Agency of Canada developed the Chronic Disease Indicator Framework (the Framework) with the goal of systematizing and enhancing chronic disease surveillance in Canada by providing the basis for consistent and reliable information on chronic diseases and their...

  • Homocysteine and high sensitivity C - reactive protein in patients with systemic lupus erythematosus, and their relation with diseases activity and cardiovascular risk factors. S., Sedighy; S., Sadani; Z., Rezaii Yazdi; R., Hatef M.; J., Tavakoli Afshar; R., Azarpazhoh M.; M., Aghai; H., Esmaeili // Journal of Gorgan University of Medical Sciences;2011, Vol. 13 Issue 1, p44 

    Background and Objective: Systemic lupus erythematosus (SLE) is an inflammatory multi-system disease with an unknown origin. In patients with lupus disease cardiovascular events is an important cause of mortality and morbidity. This study carried out to measurement of high sensitivity C...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics